VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $229,000 | +63.6% | 31,712 | +6.1% | 0.01% | +16.7% |
Q1 2020 | $140,000 | -35.2% | 29,901 | +11.3% | 0.01% | -14.3% |
Q4 2019 | $216,000 | -4.0% | 26,873 | -17.7% | 0.01% | -12.5% |
Q3 2019 | $225,000 | -10.0% | 32,672 | +8.4% | 0.01% | -11.1% |
Q2 2019 | $250,000 | -19.6% | 30,128 | -3.6% | 0.01% | -25.0% |
Q1 2019 | $311,000 | +85.1% | 31,250 | +41.9% | 0.01% | +71.4% |
Q4 2018 | $168,000 | – | 22,020 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |